ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AXGN Axogen Inc

7.55
0.04 (0.53%)
After Hours
Last Updated: 08:00:03
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Axogen Inc AXGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.04 0.53% 7.55 08:00:03
Open Price Low Price High Price Close Price Previous Close
7.49 7.38 7.575 7.55 7.51
more quote information »

Recent News

Date Time Source Heading
12/12/202308:38EDGAR2Form 144 - Report of proposed sale of securities
06/12/202323:15EDGAR2Form 8-K - Current report
06/12/202323:00GLOBEAxogen Announces Transition of Finance Team Leadership
02/12/202309:00GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
20/11/202323:00GLOBEAxogen, Inc. to Participate at the Piper Sandler 35th Annual..
08/11/202308:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:13EDGAR2Form 8-K - Current report
07/11/202323:00GLOBEAxogen, Inc. Reports 2023 Third Quarter Financial Results
18/10/202322:00GLOBEAxogen, Inc. to Report Third Quarter 2023 Financial Results..
14/10/202311:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202311:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202311:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202311:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202311:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202306:19EDGAR2Form 8-K - Current report
09/9/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202320:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202321:00GLOBEAxogen, Inc. Announces Full Launch of Axoguard HA+ Nerve..
31/8/202321:00GLOBEAxogen to Participate at Upcoming Investor Conferences
26/8/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202321:00GLOBEAxogen, Inc. Begins Processing Avance® Nerve Graft at New..
19/8/202306:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/8/202306:22EDGAR2Form 8-K - Current report
19/8/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202306:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/8/202301:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/8/202306:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:08EDGAR2Form 8-K - Current report
08/8/202306:01GLOBEAxogen, Inc. Reports 2023 Second Quarter Financial Results
27/7/202321:00GLOBEAxogen to Participate at Canaccord Genuity’s 43rd Annual..
26/7/202321:00GLOBEAxogen, Inc. to report second quarter 2023 financial results..
25/7/202306:38EDGAR2Form ARS - Annual Report to Security Holders
08/7/202306:32EDGAR2Form DEF 14A - Other definitive proxy statements
24/5/202321:00GLOBEAxogen to Participate at Jefferies Healthcare Conference
12/5/202321:00GLOBEAxogen to Participate at JMP Securities Life Sciences..
09/5/202321:00GLOBEAxogen, Inc. Reports 2023 First Quarter Financial Results
19/4/202306:05GLOBEAxogen, Inc. to report first quarter 2023 financial results..
14/3/202322:00GLOBEAxogen, Inc Reports 2022 Fourth Quarter and Full-Year..
06/3/202323:00GLOBEAxogen, Inc. Appoints Marc Began as Executive Vice President..
03/3/202308:00GLOBEAxogen, Inc. to report fourth quarter 2022 financial results..
13/2/202323:00GLOBEAxogen, Inc. Appoints Jens Schroeder Kemp as Chief..
09/1/202323:00GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com